Company
ConvaTec Group PLC
LON:CTEC
ConvaTec is a global medical products and technologies company, with leading market positions in ostomy care, wound therapeutics, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Our brands include AQUACEL® advanced wound dressings, which form a gel on contact with wound fluid, creating an optimal environment for wound healing. ConvaTec has over 8,000 employees, with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners.
83 stories
Hardware & electrical equipment
FTSE reshuffle confirmed with investment trusts on the rise, while Cineworld and Made.com drop out of All-Share
Asset manager Abrdn, Howden Joinery and genetic medicines maker Hikma were all relegated from London's top-flight index into the FTSE 250
ConvaTec: Wall Street bank thinks you may bag a bargain
JP Morgan believes margin concerns may be a tad overdone
ConvaTec's caveats, issues and margin troubles lead to downgrade from RBC Capital
Higher input costs and freight costs are not able to be passed on to customers in the near-term, "and it is not clear about the mid-term either"
ConvaTec turnaround worries unfounded, says broker
Analysts at Peel Hunt said the medical products firm had beaten expectations in its first-half results last August and again in its third quarter, while also delivering strong numbers in its final results and in the first quarter of the cur
ConvaTec keeps dividend as it expects full-year revenue growth
Revenue is expected to rise by 2-3.5% in the year to December
ConvaTec higher as it maintains 2020 outlook and dividend but warns of increased risk from coronavirus
The FTSE 250 medical equipment maker also reported a "robust" first quarter with revenues up 6.9% at US$460mln
ConvaTec sacrifices profits for turnaround plan
Profits crashed 91% but revenue and dividend were flat
ConvaTec downgraded to ‘underweight’ by JP Morgan to reflect turnaround risk
The price target was trimmed to 168p from 171p, a 20% discount to the sector, while analysts say the product pipeline is “at an all-time low”
ConvaTec stumbles on RBC downgrade as “bumpy ride” ahead
The FTSE 250-listed company will see a tough last quarter while full-revenues will come in at the bottom of consensus range
ConvaTec Group keeps full-year guidance unchanged
The FTSE 250-listed firm expects revenue to grow between 1% and 2.5%, with adjusted underlying margin up between 18% to 20%
ConvaTec appoints seasoned transformation guru as chairman
The interim chairman highlighted his replacement's “wealth of experience” in senior roles in “companies undertaking transformation”
Archive
Last 'super Thursday' before Brexit as BoE, Shell and LSE updates eyed
On 1 August, other half-year updates include British American Tobacco, Barclays, Standard Chartered and Capita
Archive
Week ahead preview: Lloyds, Barclays, RBS, BT Group, BoE and US Fed
It will be a busy week for markets with a barrage of corporate earnings and interest rates decisions from the Bank of England and the US Federal Reserve.
ConvaTec shares drop as first-quarter revenues fall across the board
The only region or division to show any growth in the first quarter was Asia Pacific, which makes up less than a tenth of total revenue
Investments and investor services
FTSE 100 closes higher after strong US jobs report boosts markets
Footsie closed up over 29 points on the day to close at 7,380, while the FTSE 250 added over 18 at 19,795
Archive
HSBC to post weaker first quarter earnings as it tackles China slowdown
The day ahead includes first quarter earnings from HSBC and the all-important US non-farm payrolls report
Citi initiates coverage on ConvaTec with a ‘neutral’ rating, thinks it is too early to buy the stock
Citi's analysts pointed out that ConvaTec is the cheapest MedTech stock in its universe although it operates in “structurally attractive markets and has a solid turnaround plan”
ConvaTec hits the skids as full-year numbers and 2019 guidance disappoint
ConvaTec shares dropped more than 20% early on Thursday morning as its results, but more importantly its guidance, disappointed investors
Archive
FTSE 100 closes a tad higher but sentiment dented by US data
FTSE 100 closed up just over six points at 7,197, while FTSE 250 shed over 74 at 18,898
Archive
Drug firms AstraZeneca and Indivior to be in spotlight on Thursday
AstraZeneca, Indivior and Coca-Cola HBC are among the higher profile names in the schedule for Thursday.
Archive
Blue-chip corporate update mill to continue to grind, with RBS and AstraZenca to the fore
Aside from all the company news, the Week Ahead also brings the latest UK inflation and GDP growth data for investors to digest, while the Brexit saga will continue to roll on
Investments and investor services
FTSE 100 closes firmly ahead as it puts dismal October to rest
The FTSE 100 closed up around 92 points at 7,182. FTSE 250 also gained..
Archive
Glaxo getting the tingles from its shingles jab
Trading updates from Glaxo, Standard Chartered and Next are likely to be the highlights
Archive
UK Budget, BoE, US jobs data to sandwich flood of corporate updates from likes of BP and Shell
Aside from the oil majors, the slew of blue-chip updates due in the coming week will include global banks HSBC and Standard Chartered, and drugs firms GlaxoSmithKlne and Shire
ConvaTec downgraded by UBS due to "further earnings risk"
UBS analysts are concerned about ConvaTec's prospects without a CEO and after high senior staff turnover since IPO
ConvaTec announces resignation of chief executive as it issues profit warning
Former Johnson & Johnson chairman Rick Anderson has been appointed interim chief executive of ConvaTec
Investments and investor services
FTSE 100 closes positively as PM Theresa May says gov't is working towards a good Brexit deal
Britain's blue-chip benchmark finished up around 31 points at 7,029
ConvaTec sees profits jump by over a third in first half
The FTSE 250 medical products company recorded an operating profit for the period of US$122mln, a 31.5% increase on the same period last year
Archive
FTSE 100 joins European stocks to close lower as trade worries weigh
FTSE 100 lost almost 77 points to close the day at 7,575, while FTSE 250 was also down, off over 252 points at 20,548
Archive
Bank of England widely expected to hike rates but will the decision be unanimous?
A month ago, a rate hike of a quarter of a point seemed nailed on. Most economists still think it is the most likely outcome but the decision may not be unanimous given some recent iffy economic data
Archive
Banks in the foreground as the BoE and Fed make rate decisions; Barclays, Lloyds, RBS all report results
Aside from the raft of banking numbers in the Week Ahead, the likes of BP, Centrica, Next, Rolls-Royce, BAE Systems and Taylor Wimpey will also continue the FTSE 100 reporting splurge
Investments and investor services
FTSE 100 rises for fifth session a row, buoyed by miners
The FTSE 100 continued higher on Wednesday, extending the week's winning streak.
Archive
Hong Kong loan growth, US interest rate rises expected to lift Standard Chartered profit
Day ahead includes updates from FTSE 100 lender Standard Chartered PLC, drugs firm indivior PLC, plus the latest Federal Reserve interest rate decision
Archive
Asia to drive quarterly earnings growth at HSBC and Standard Chartered
Another busy week of earnings from FTSE 350 companies awaits
Archive
Topps Tiles, IAG, easyJet, Electrocomponents and US jobs in focus after Easter break
The week ahead includes interims from Topps Tiles, traffic statistics from easyJet and IAG, a trading statement from Electrocomponents and the US non-farm payrolls report
ConvaTec 2017 profits fall on supply issues and lower sales of new products
ConvaTec Group expects organic revenue growth to accelerate in 2018
Investments and investor services
FTSE 100 closes up, boosted by mining stocks and as pound strengthens against the dollar
The UK's blue-chip index closes up 20.84 points to 7,234.81
Investments and investor services
RELX and ConvaTec among the names in Thursday’s diary
RELX is expected to see revenue and profit growth, whereas ConvaTec will report on what's seen as a disappointing year.
Archive
Inflation numbers from UK and US to be eyed closely in coming week amid rate hike fears
Week ahead includes the latest UK and US consumer price indexes, plus corporate updates from RELX PLC, Coca Cola HBC PLC, Shire PLC and ConvaTec PLC
ConvaTec heads higher as City broker upgrades to ‘hold’ ahead of new year
Numis analyst Paul Cuddon thinks the balance between risk and reward is now more fairly balanced
Investments and investor services
FTSE 100 closes higher as miners gain and sterling slides
The FTSE 100 closed the day higher, as the weak pound helped, while other European indices lagged
JPMorgan ups Just Eat's price target a day after its promotion to the FTSE 100 was confirmed
In a review of the European takeaway sector, the US bank reiterated an ‘overweight’ stance on the UK firm with an increased price target of 967p, up from 841p previously
Investments and investor services
All eyes on Primark as Associated British Foods releases results
AB Foods saw its shares fall after a pre-close season update as worries over cost pressures in its grocery business, but, the Primark fashion retail unit will likely be the focus for many.
Archive
M&S and Sainsbury's take centre stage as BoE interest rate hike excitement dies down
The week ahead includes earnings from M&S, Sainsbury's, ABF, Direct Line, Wetherspoon and AstraZeneca while macro-economic announcements will be thin on the ground
Greatland Gold surges again after Ernest Giles project extension move
A look at some of the biggest risers and fallers today in London
Koovs jumps on partnership deal with online clothing retailer N Brown
A look at some of the biggest risers and fallers today in London
ConvaTec lowers revenue guidance after supply issues hit third-quarter performance
Costs associated with supply issues during the third quarter are expected to hit margins
FTSE 100 closes in negative territory despite resource stock gains
The UK blue chip index closed at 7,526, well below the session peak of 7,557.00 and close to the day’s low of 7,531.48
FTSE 100 closes higher despite weak Wall Street
Thursday lunch brought no surprises from the ECB, with the European Central Bank making no changes to interest rates.
Archive
Biffa, Bovis and Go-Ahead results all due, but ECB policy decision to take centre stage
Some big names are due to publish results on Thursday, but the European Centeal Bank’s decision on interest rates is what most traders will be waiting on
Archive
Barrage of builders to update in week ahead with Brexit concerns remaining key
Week ahead includes updates from a raft of housebuilders, including Barratt Developments, Berkeley Group and Bovis Homes, plus trading news from Halfords Group, and the latest European Central Bank Council meeting
Well-received earnings gives Plus500 a boost
A look at some of the biggest risers and fallers in London today
FTSE 100 closes at 7,531 as new highs come in to view
The FTSE 100 index closed up 20.23 at 7,531, below the session peak of 7,533.74 and well above the day’s low of 7,511.71
FTSE 100 ends lower but European shares fare worse
London stocks were on the front foot this morning, but they quickly retreated this afternoon...
FTSE100 closes a tad lower as eyes and nerves turn to election
FTSE100 subdued after latest poll points to hung parliament
FTSE 100 closes higher as UK services data provides cheer
The FTSE 100 ended up 13.57 at 7,248 as investors weigh economic data and corporate earnings
Archive
Cash flow in focus as Royal Dutch Shell releases results on Thursday
Royal Dutch Shell and supermarket retailer Morison set to be among Thursday's highlights.
Archive
HSBC may struggle to match rivals
HSBC is the last of the big four banks to report with more uncertainty over the outcome than for its UK-centric rivals.
Six FTSE 100 giants you have (probably) never heard of
They've made it into the FTSE 100 without ever being in danger of making it to the front pages of the national dailies. Is it worth getting to know these companies better?
Archive
FTSE shares fall ahead of Budget, as Paddy Power Betfair slumps
FTSE 100 shares end lower on Tuesday ahead of the Spring Budget speech on Wednesday and as Paddy Power Betfair shares slump
ConvaTec's shares gain as full year earnings grow after IPO
The group, which floated in London last October, reported an increase in revenue to $1.7bn in the year ended 31 December 2016, from $1.6bn a year earlier
FTSE shares end flat, give back record peaks, except Vesuvius
FTSE 100 stocks ends flat on Thursday after falling back from a fresh record high as shares in outsourcing group Capita slumped 9%
Investments and investor services
Can Cobham avoid a sixth profit warning when it releases full year results?
Cobham, Sportech, Travis Perkins, Capita and GoCompare are among the names on Thursday's list.
Archive
Week ahead: ITV set to broadcast results as quantity set to rule over quality
Having seen the big drugs, oils, and banking sectors dominate over the past few weeks, investors will have less FTSE 100 results to digest in the coming week.
Clinigen, Convatec and Sinclair Pharma stand out among mid-cap pharmas says Peel Hunt
Clinigen is a core pick as a defensive GARP (growth at reasonable price) play.
Archive
Proactive news round-up: Range Resources, LGO Energy, Corero Network Security ...
A glance at some of the stories on the Proactive newswire today
ConvaTec increases footprint in France and Benelux
EuroTec manufactures and distributes one- and two-piece ostomy systems and accessories
More good news for ConvaTec as Deutsche starts with buy
After gaining elevation to the FTSE 100 in last week’s quarterly reshuffle, colostomy bag maker ConvaTec got some more good news today as broker Deutsche Bank started coverage on the stock with a buy rating.
Convatec dresses wounded IPO market with £1.5bn float
Against a tide of negativity, the British wound dressings maker has successfully completed the biggest flotation in London this year